– XPOVIO® is the first and only approved XPO1 inhibitor in Indonesia. – From the second half of 2024 to now, XPOVIO® was successively approved in Thailand, Malaysia and Indonesia, significantly expanding Antengene’s commercial presence in APAC. To date, XPOVIO® has been approved for…